top of page
Search

UCSF and Stanford Launch $200 Million Cancer Research Hub

  • rezahariri
  • Aug 9
  • 1 min read
ree

In July 2025, a transformative collaboration between the UCSF Helen Diller Family Comprehensive Cancer Center and the Stanford Cancer Institute culminated in the establishment of the Weill Cancer Hub West. This ambitious $200 million initiative, propelled by a $100 million matching grant from the Weill Family Foundation, aims to revolutionize cancer research and treatment over the next decade. Both institutions have committed to raising an additional $50 million each, bringing the total funding to $200 million .

The hub's inaugural projects include:

  • Project VITAL: Developing next-generation cellular therapies using CRISPR technology to engineer immune cells directly within the body.Sonoma Index-Tribune+1

  • Project PROMISE: Leveraging artificial intelligence and cellular engineering to precisely target and destroy treatment-resistant solid tumors.Home+2Home+2

  • Project FEAST: Investigating the role of diet and metabolic interventions, including GLP-1 drugs like Ozempic, in reducing cancer development and progression.Sonoma Index-Tribune

  • Project IMPACT: Creating AI systems that integrate clinical and biological data for personalized cancer treatments.Home+2Home+2

This collaborative effort marks a significant milestone in cancer research, combining the expertise of two leading institutions to accelerate the development of innovative therapies and improve patient outcomes .

 
 
 

Comments

Inspiring a New Era of Investing ● Committed to Exceptional Outcomes ● Leading the Evolution of Wealth ● Tech-Driven Insight ●

GARC-logo-CMYK-white-wb.png

Home

Investing With Us

Our Strategies

Insights

Who we are

Partner with Us

​

images.png

LinkedIn/GrandArc

Privacy Policy

Request Access

Notices

Terms of Use

Contact us

The information contained on this website is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities or investment products in any jurisdiction where such an offer or solicitation would be unlawful.

Grand Arc Capital is a Cayman Islands-registered and CIMA-regulated investment advisor. Investment products referenced herein may not be registered under the securities laws of any jurisdiction, including the United States, Canada, or any EU Member State, and may not be offered or sold in such jurisdictions without compliance with applicable securities laws or regulatory exemptions.

This content is not directed at, and may not be accessed by, any person or entity in a jurisdiction where such distribution, publication, or use would be contrary to local law or regulation.

Past performance is not a reliable indicator of future results. All investments involve risk, including the possible loss of principal. Prospective investors should conduct their own due diligence and consult their legal, tax, and financial advisors before making any investment decision.

Accessing this website and its materials implies your acknowledgment and acceptance of these terms.

Copyright ©2025 Grand Arc Capital. All rights reserved.

bottom of page